This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
PEB or OHI: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PEB vs. OHI: Which Stock Is the Better Value Option?
MPW vs. OHI: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
MPW vs. OHI: Which Stock Is the Better Value Option?
MPW or OHI: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MPW vs. OHI: Which Stock Is the Better Value Option?
Best Income Stocks to Buy for August 7th
by Zacks Equity Research
OHI, AEO and APOG made it to the Zacks Rank #1 (Strong Buy) income stocks list on August 7, 2024.
Omega Healthcare Investors (OHI) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Omega Healthcare Investors (OHI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Compared to Estimates, Omega Healthcare Investors (OHI) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Omega Healthcare Investors (OHI) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Omega Healthcare Investors (OHI) Tops Q2 FFO and Revenue Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of 2.90% and 1.30%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Omega Healthcare Investors (OHI) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Omega Healthcare Investors (OHI), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2024.
PEB vs. OHI: Which Stock Is the Better Value Option?
by Zacks Equity Research
PEB vs. OHI: Which Stock Is the Better Value Option?
Best Income Stocks to Buy for July 16th
by Zacks Equity Research
USAC, WES and OHI made it to the Zacks Rank #1 (Strong Buy) income stocks list on July 16, 2024.
PGRE vs. OHI: Which Stock Is the Better Value Option?
by Zacks Equity Research
PGRE vs. OHI: Which Stock Is the Better Value Option?
Omega Healthcare Investors (OHI) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
PGRE vs. OHI: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
PGRE vs. OHI: Which Stock Is the Better Value Option?
Omega Healthcare Investors (OHI) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Omega Healthcare Investors (OHI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
PGRE or OHI: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PGRE vs. OHI: Which Stock Is the Better Value Option?
PGRE vs. OHI: Which Stock Is the Better Value Option?
by Zacks Equity Research
PGRE vs. OHI: Which Stock Is the Better Value Option?
Omega Healthcare Investors (OHI) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Omega Healthcare Investors (OHI) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Omega Healthcare Investors (OHI) Beats Q1 FFO and Revenue Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of 4.62% and 1.40%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
National Storage (NSA) Lags Q1 FFO Estimates
by Zacks Equity Research
National Storage (NSA) delivered FFO and revenue surprises of -1.64% and 0.68%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Regency Centers (REG) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Healthy demand for Regency Centers' (REG) shopping centers and strategic acquisitions are likely to have benefited the company's Q1 earnings. However, higher interest rates might have ailed.
Community Healthcare Trust (CHCT) Lags Q1 FFO and Revenue Estimates
by Zacks Equity Research
Community Healthcare Trust (CHCT) delivered FFO and revenue surprises of -1.67% and 1.44%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Can Arbor Realty (ABR) Retain Its Beat Streak in Q1 Earnings?
by Zacks Equity Research
While growth in servicing revenues is expected to have aided Arbor Realty's (ABR) Q1 earnings, a decline in revenues from mortgage servicing rights is likely to have been a headwind.
What's in Store for Federal Realty (FRT) This Earnings Season?
by Zacks Equity Research
Federal Realty's (FRT) first-quarter results are likely to gain from the healthy leasing activity, though tenant bankruptcies and higher interest expenses act as dampeners.
ESRT vs. OHI: Which Stock Is the Better Value Option?
by Zacks Equity Research
ESRT vs. OHI: Which Stock Is the Better Value Option?
Why Investors Need to Take Advantage of These 2 Finance Stocks Now
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.